Profile data is unavailable for this security.
About the company
Shenzhen Neptunus Interlong Bio-technique Co Ltd is a China-based company principally engaged in the research and development, manufacturing and selling of medicines and medical devices, and the purchase and sales of medicines, healthcare food products and medical devices. The Company operates its businesses through two segments. The Manufacturing and Selling of Medicines and Medical Devices segment is mainly engaged in manufacturing, sales of medicines and medical devices. The Sales and Distribution of Medicines, Healthcare Products and Medical Devices segment is mainly engaged in sales and distribution of medicines, healthcare products and medical devices. The Company mainly operates its businesses in the domestic market.
- Revenue in HKD (TTM)1.13bn
- Net income in HKD7.01m
- Incorporated1994
- Employees1.47k
- LocationShenzhen Neptunus Interlong Bio-technique Co Ltd1F, Block 1, Research BuildingNeptunus Technical CenterSHENZHEN 518000ChinaCHN
- Phone+86 75 526411869
- Fax+86 75 586391610
- Websitehttps://www.interlong.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sanai Health Industry Group Co Ltd | 108.77m | -37.78m | 60.39m | 147.00 | -- | 0.1737 | -- | 0.5553 | -0.247 | -0.1184 | 0.711 | 2.27 | 0.1994 | 8.97 | 9.71 | 663,207.20 | -7.70 | 3.50 | -10.97 | 5.00 | 17.61 | 37.40 | -38.60 | 10.86 | 2.58 | -6.86 | 0.1487 | 0.00 | -20.92 | 0.8085 | -176.60 | -- | -9.02 | -- |
| PuraPharm Corp Ltd | 346.76m | -38.56m | 168.81m | 469.00 | -- | 1.23 | 11.58 | 0.4868 | -0.0976 | -0.0976 | 0.8778 | 0.2568 | 0.4749 | 1.39 | 6.98 | 723,920.70 | -5.28 | -6.50 | -15.35 | -14.97 | 53.93 | 59.22 | -11.12 | -14.08 | 0.3313 | -1.14 | 0.7865 | -- | -6.09 | -11.30 | 66.59 | -- | -29.92 | -- |
| Kontafarma China Holdings Ltd | 891.73m | -362.77m | 173.25m | 655.00 | -- | 0.2529 | -- | 0.1943 | -0.065 | -0.065 | 0.1598 | 0.1226 | 0.6269 | 4.43 | 7.06 | 1,296,115.00 | -29.24 | -2.95 | -39.76 | -4.38 | 55.36 | 55.42 | -46.64 | -7.85 | 0.8036 | -- | 0.2753 | -- | 10.93 | -0.5183 | -161.89 | -- | -31.47 | -- |
| Extrawell Pharmaceutical Holdings Ltd | 52.65m | -337.89m | 204.00m | 161.00 | -- | 0.2285 | -- | 3.88 | -0.1351 | -0.1352 | 0.0219 | 0.3501 | 0.0422 | 10.54 | 5.89 | 322,975.50 | -27.00 | 3.07 | -28.13 | 3.21 | 42.41 | 47.65 | -640.53 | 59.77 | 13.00 | -0.037 | 0.146 | -- | -6.21 | -6.50 | 236.70 | 21.75 | 80.07 | -- |
| Tianda Pharmaceuticals Ltd | 310.50m | -67.37m | 236.50m | 624.00 | -- | 0.4867 | -- | 0.7617 | -0.0313 | -0.0313 | 0.1444 | 0.226 | 0.3931 | 2.84 | 5.14 | 442,937.20 | -8.57 | -- | -12.38 | -- | 42.76 | -- | -21.80 | -- | 0.6900 | -15.81 | 0.2183 | -- | -37.99 | -- | -154.07 | -- | -- | -- |
| Hin Sang Group (Interntnl) Hldng Co Ltd | 95.53m | -40.10m | 239.10m | 185.00 | -- | 1.69 | -- | 2.50 | -0.0367 | -0.0367 | 0.0875 | 0.1299 | 0.1679 | 2.42 | 12.62 | 459,278.80 | -7.03 | -5.77 | -13.64 | -8.41 | 67.28 | 58.19 | -41.89 | -36.55 | 0.0735 | -0.3333 | 0.7032 | -- | -0.7882 | -12.21 | -34.48 | -- | -50.36 | -- |
| Shenzhen Neptunus Intrlng Bi tchnq CoLtd | 1.13bn | 7.01m | 261.77m | 1.47k | 37.30 | 0.3257 | 6.21 | 0.2319 | 0.0042 | 0.0042 | 0.6726 | 0.479 | 0.783 | 3.68 | 5.65 | 759,990.90 | -0.4295 | 2.52 | -0.6329 | 3.76 | 29.12 | 43.41 | -0.5486 | 3.33 | 1.48 | 2.03 | 0.1157 | 139.17 | -2.18 | -0.7356 | 3.68 | -15.97 | -7.87 | -- |
| Regent Pacific Group Ltd | 7.16m | -31.88m | 262.63m | 17.00 | -- | -- | -- | 36.70 | -0.1389 | -0.1389 | 0.0312 | -0.1117 | 1.20 | -- | 6.96 | 420,948.40 | -535.26 | -47.86 | -- | -61.88 | -- | -- | -445.46 | -1,658.64 | -- | -11.90 | -- | -- | 153.63 | 2.17 | 82.11 | -- | -5.59 | -- |
| Wai Yuen Tong Medicine Holdings Ltd | 721.27m | -13.83m | 382.54m | 726.00 | -- | 0.3234 | 5.17 | 0.5304 | -0.0123 | -0.0123 | 0.6411 | 1.05 | 0.4165 | 1.41 | 9.68 | 950,292.50 | -0.7998 | -1.81 | -1.06 | -3.10 | 49.87 | 44.67 | -1.92 | -11.19 | 0.7806 | -- | 0.2033 | -- | -4.92 | 3.73 | 126.62 | -56.16 | 31.89 | -- |
| China NT Pharma Group Co Ltd | 21.20m | -80.60m | 498.94m | 21.00 | -- | -- | -- | 23.53 | -0.2338 | -0.2338 | 0.0489 | -0.4667 | 0.0546 | -- | 3.09 | 963,780.60 | -20.76 | -10.31 | -- | -- | 51.27 | -- | -380.13 | -97.11 | 0.0447 | -0.3973 | 7.95 | -- | 415.34 | -24.38 | -59.32 | -- | -71.03 | -- |
| Uni-Bio Science Group Ltd | 589.59m | 91.35m | 644.89m | 504.00 | 7.09 | 1.68 | 5.63 | 1.09 | 0.0152 | 0.0152 | 0.0976 | 0.0641 | 1.13 | 3.62 | 9.18 | 1,210,657.00 | 17.51 | 6.21 | 22.17 | 8.56 | 82.19 | 80.72 | 15.49 | 4.96 | 3.22 | 59.39 | 0.22 | 1,633.58 | 14.08 | 21.43 | 16.79 | 102.04 | 32.65 | -- |
Data as of Mar 04 2026. Currency figures normalised to Shenzhen Neptunus Interlong Bio-technique Co Ltd's reporting currency: Hong Kong Dollar HKD
